129 related articles for article (PubMed ID: 36716178)
1. Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States.
Devasia TP; Mariotto AB; Nyame YA; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):659-665. PubMed ID: 36716178
[TBL] [Abstract][Full Text] [Related]
2. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
3. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ
Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
5. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
6. Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden.
Merrill RM
J Epidemiol Community Health; 2001 Mar; 55(3):191-7. PubMed ID: 11160174
[TBL] [Abstract][Full Text] [Related]
7. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
8. The impact of race on survival in metastatic prostate cancer: a systematic literature review.
Freedland SJ; Samjoo IA; Rosta E; Lansing A; Worthington E; Niyazov A; Nazari J; Arondekar B
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):461-474. PubMed ID: 37592001
[TBL] [Abstract][Full Text] [Related]
9. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Steele CB; Li J; Huang B; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
[TBL] [Abstract][Full Text] [Related]
13. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
14. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the Number of Individuals Living With Metastatic Cancer in the United States.
Gallicchio L; Devasia TP; Tonorezos E; Mollica MA; Mariotto A
J Natl Cancer Inst; 2022 Nov; 114(11):1476-1483. PubMed ID: 35993614
[TBL] [Abstract][Full Text] [Related]
16. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
17. Is prostate cancer different in black men? Answers from 3 natural history models.
Tsodikov A; Gulati R; de Carvalho TM; Heijnsdijk EAM; Hunter-Merrill RA; Mariotto AB; de Koning HJ; Etzioni R
Cancer; 2017 Jun; 123(12):2312-2319. PubMed ID: 28436011
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.
Mariotto AB; Etzioni R; Hurlbert M; Penberthy L; Mayer M
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):809-815. PubMed ID: 28522448
[No Abstract] [Full Text] [Related]
19. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
20. Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.
Altekruse SF; Huang L; Cucinelli JE; McNeel TS; Wells KM; Oliver MN
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1460-7. PubMed ID: 20501756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
